Psilocybin, the psychedelic substance present in some hallucinogenic mushrooms, seems to have an interesting ability: promoting the formation of new connections between neurons and protecting those damaged by chronic stress. The researchers observed these changes as early as the first 24 hours after administration. And they discovered something even more curious: the mechanism responsible for reorganizing brain connections can work independently of any of the responses associated with psychedelic effects.
The discovery comes from a study published in Nature Neuroscienceconducted by researchers at the University of California at Santa Cruz, under the leadership of neuroscientist Yi Zuo. Through preclinical experiments, the team has identified a cellular mechanism that could contribute to the development of new treatments for depression and other psychiatric disorders, exploiting the properties of psilocybin without necessarily having to reproduce its intense psychedelic experience.
How psilocybin helps the brain rebuild neuronal connections
To understand what happens in the brain after taking psilocybin, scientists used two-photon microscopy, a technique that allows them to observe tiny neuronal structures and follow their changes over time. They focused on the so-called dendritic spines, small protuberances that participate in the formation of synapses, i.e. the contact points through which neurons communicate with each other. Fundamental structures for learning, memory and the functioning of brain circuits.
Already in the first 24 hours after administration, the researchers observed an increase in new dendritic spines. Not only that: many of these structures have reached a mature form more quickly, associated with more stable connections. Psilocybin, therefore, seems to favor the brain’s ability to build and consolidate new connections, a process that is part of the so-called neuroplasticity.
But there is an interesting detail. The substance did not limit itself to increasing the number of connections, because it also modified those already present. In experiments without prior exposure to chronic stress, the initial formation of new spines progressively decreased over the following three weeks, while some pre-existing connections were eliminated. The brain has therefore started a real reorganization of its circuits, making room for new connections and modifying the previous ones.
Chronic stress changes the response to psilocybin
The results became even more interesting when researchers examined the effects of psilocybin after prolonged exposure to stress. Under these conditions, the substance favored a particularly intense formation of new neuronal connections, while simultaneously reducing the loss of existing ones. A double action that suggests a possible role for psilocybin in the recovery of brain circuits altered by stress.
According to Yi Zuo, professor of molecular, cellular and developmental biology at the University of California, the findings challenge the idea that psilocybin works by simply increasing neuronal connections. The response seems to depend on the initial conditions of the brain: in the presence of chronic stress, the substance also promotes the preservation of existing structures, while in other conditions it stimulates a broader reorganization.
A difference that is anything but marginal. Prolonged stress can impair the functioning of circuits involved in emotion regulation and contribute to the loss of synaptic connections. The possibility of promoting recovery has long interested research on mood disorders, especially to understand how to intervene on the brain changes associated with depression.
The effects on the brain can be separated from the psychedelic ones
The second part of the research addresses a particularly delicate question: to obtain the effects of psilocybin on neuroplasticity, is it really necessary to also activate the mechanisms responsible for the psychedelic experience? To search for an answer, scientists examined serotonin 5-HT2A receptors, involved in the action of psychedelics, focusing on a specific population of neurons in the cerebral cortex.
Through targeted genetic modifications, they restored these receptors exclusively in the pyramidal neurons of the fifth layer of the cortex. Psilocybin continued to encourage the formation and maturation of new connections, but without causing the characteristic head movement used in experiments as an indicator of psychedelic activity. However, when the same receptors were selectively eliminated, the neuronal remodeling disappeared, while the behavioral response remained.
The result suggests that the formation of new connections and some responses associated with psychedelic effects follow distinct cellular mechanisms. The observed movement is an experimental indicator and not a direct measure of hallucinations, but the separation obtained offers researchers a valuable indication: it may be possible to stimulate neuroplasticity by acting on specific circuits, without necessarily activating all the responses typical of psychedelic substances.
New drugs against depression without hallucinogenic effects?
Psilocybin is already the focus of numerous clinical research for the treatment of depression and other psychiatric disorders. Its use, however, involves intense effects on perception and state of consciousness, which require a controlled environment and adequate clinical supervision. Identifying the mechanism responsible for neuronal changes could allow us to develop substances capable of exploiting some of its properties without necessarily causing the psychedelic experience itself.
This is the perspective indicated by the authors of the study. Knowing which receptors and which cells are involved in the formation of connections could help design new, more selective drugs capable of acting on the brain circuits involved in mood disorders. An ambitious goal, which will require further experiments to verify whether the structural changes observed can be transformed into therapeutic benefits in people too.
For now, researchers have identified a biological mechanism, without yet having developed a drug capable of selectively reproducing it. But the discovery adds an important piece to research on psychedelics: the effects of psilocybin on neuronal connections could be exploited even without reproducing all the consequences of its psychedelic activity. The next work will be to understand how to achieve this result with a molecule that can be used in medicine.